BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16381009)

  • 1. Inhibition of human prostate cancer growth, osteolysis and angiogenesis in a bone metastasis model by a novel mechanism-based selective gelatinase inhibitor.
    Bonfil RD; Sabbota A; Nabha S; Bernardo MM; Dong Z; Meng H; Yamamoto H; Chinni SR; Lim IT; Chang M; Filetti LC; Mobashery S; Cher ML; Fridman R
    Int J Cancer; 2006 Jun; 118(11):2721-6. PubMed ID: 16381009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-10 inhibition of human prostate PC-3 ML cell metastases in SCID mice: IL-10 stimulation of TIMP-1 and inhibition of MMP-2/MMP-9 expression.
    Stearns ME; Fudge K; Garcia F; Wang M
    Invasion Metastasis; 1997; 17(2):62-74. PubMed ID: 9561025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimetastatic activity of a novel mechanism-based gelatinase inhibitor.
    Krüger A; Arlt MJ; Gerg M; Kopitz C; Bernardo MM; Chang M; Mobashery S; Fridman R
    Cancer Res; 2005 May; 65(9):3523-6. PubMed ID: 15867341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinase activity, bone matrix turnover, and tumor cell proliferation in prostate cancer bone metastasis.
    Nemeth JA; Yousif R; Herzog M; Che M; Upadhyay J; Shekarriz B; Bhagat S; Mullins C; Fridman R; Cher ML
    J Natl Cancer Inst; 2002 Jan; 94(1):17-25. PubMed ID: 11773278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maspin expression inhibits osteolysis, tumor growth, and angiogenesis in a model of prostate cancer bone metastasis.
    Cher ML; Biliran HR; Bhagat S; Meng Y; Che M; Lockett J; Abrams J; Fridman R; Zachareas M; Sheng S
    Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7847-52. PubMed ID: 12788977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone.
    Nemeth JA; Harb JF; Barroso U; He Z; Grignon DJ; Cher ML
    Cancer Res; 1999 Apr; 59(8):1987-93. PubMed ID: 10213511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenovirus-mediated expression of TIMP-1 and TIMP-2 in bone inhibits osteolytic degradation by human prostate cancer.
    Deng X; He G; Levine A; Cao Y; Mullins C
    Int J Cancer; 2008 Jan; 122(1):209-18. PubMed ID: 17847032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, kinetic characterization and metabolism of diastereomeric 2-(1-(4-phenoxyphenylsulfonyl)ethyl)thiiranes as potent gelatinase and MT1-MMP inhibitors.
    Gooyit M; Lee M; Hesek D; Boggess B; Oliver AG; Fridman R; Mobashery S; Chang M
    Chem Biol Drug Des; 2009 Dec; 74(6):535-46. PubMed ID: 19824893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic gelatinases inhibitor attenuates electromagnetic pulse-induced blood-brain barrier disruption by inhibiting gelatinases-mediated ZO-1 degradation in rats.
    Qiu LB; Zhou Y; Wang Q; Yang LL; Liu HQ; Xu SL; Qi YH; Ding GR; Guo GZ
    Toxicology; 2011 Jul; 285(1-2):31-8. PubMed ID: 21501651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective inhibition of matrix metalloproteinase-9 attenuates secondary damage resulting from severe traumatic brain injury.
    Hadass O; Tomlinson BN; Gooyit M; Chen S; Purdy JJ; Walker JM; Zhang C; Giritharan AB; Purnell W; Robinson CR; Shin D; Schroeder VA; Suckow MA; Simonyi A; Sun GY; Mobashery S; Cui J; Chang M; Gu Z
    PLoS One; 2013; 8(10):e76904. PubMed ID: 24194849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of MMP-9 by a selective gelatinase inhibitor protects neurovasculature from embolic focal cerebral ischemia.
    Cui J; Chen S; Zhang C; Meng F; Wu W; Hu R; Hadass O; Lehmidi T; Blair GJ; Lee M; Chang M; Mobashery S; Sun GY; Gu Z
    Mol Neurodegener; 2012 May; 7():21. PubMed ID: 22587708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of noggin inhibits BMP-mediated growth of osteolytic prostate cancer lesions.
    Feeley BT; Krenek L; Liu N; Hsu WK; Gamradt SC; Schwarz EM; Huard J; Lieberman JR
    Bone; 2006 Feb; 38(2):154-66. PubMed ID: 16126463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testosterone-induced matrix metalloproteinase activation is a checkpoint for neuronal addition to the adult songbird brain.
    Kim DH; Lilliehook C; Roides B; Chen Z; Chang M; Mobashery S; Goldman SA
    J Neurosci; 2008 Jan; 28(1):208-16. PubMed ID: 18171938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small-molecule MMP2/MMP9 inhibitor SB-3CT modulates tumor immune surveillance by regulating PD-L1.
    Ye Y; Kuang X; Xie Z; Liang L; Zhang Z; Zhang Y; Ma F; Gao Q; Chang R; Lee HH; Zhao S; Su J; Li H; Peng J; Chen H; Yin M; Peng C; Yang N; Wang J; Liu J; Liu H; Han L; Chen X
    Genome Med; 2020 Sep; 12(1):83. PubMed ID: 32988398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of gene expression and inhibition of experimental prostate cancer bone metastasis by dietary genistein.
    Li Y; Che M; Bhagat S; Ellis KL; Kucuk O; Doerge DR; Abrams J; Cher ML; Sarkar FH
    Neoplasia; 2004; 6(4):354-63. PubMed ID: 15256057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoassays of the metalloproteinase (MMP-2) and tissue inhibitor of metalloproteinase (TIMP 1 and 2) levels in noninvasive and metastatic PC-3 clones: effects of taxol.
    Stearns ME; Wang M
    Oncol Res; 1994; 6(4-5):195-201. PubMed ID: 7841542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of cyclooxygenase-2 (COX-2) inhibition on human prostate cancer induced osteoblastic and osteolytic lesions in bone.
    Gamradt SC; Feeley BT; Liu NQ; Roostaeian J; Lin YQ; Zhu LX; Sharma S; Dubinett SM; Lieberman JR
    Anticancer Res; 2005; 25(1A):107-15. PubMed ID: 15816526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RANKL acts directly on RANK-expressing prostate tumor cells and mediates migration and expression of tumor metastasis genes.
    Armstrong AP; Miller RE; Jones JC; Zhang J; Keller ET; Dougall WC
    Prostate; 2008 Jan; 68(1):92-104. PubMed ID: 18008334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of tetracycline as an inhibitor of matrix metalloproteinase activity secreted by human bone-metastasizing cancer cells.
    Duivenvoorden WC; Hirte HW; Singh G
    Invasion Metastasis; 1997; 17(6):312-22. PubMed ID: 9949290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformational analyses of thiirane-based gelatinase inhibitors.
    Lee M; Hesek D; Shi Q; Noll BC; Fisher JF; Chang M; Mobashery S
    Bioorg Med Chem Lett; 2008 May; 18(10):3064-7. PubMed ID: 18083555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.